Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Aurilia

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
International Journal of Geriatric Psychiatry|December 19, 2001
Tardive dyskinesias in the elderlyG Fabbrini, P Barbanti, C Aurilia
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 14, 2010
Hypertension as a risk factor for migraine chronificationP Barbanti, C Aurilia, G Egeo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 29, 2014
Treatment of tension-type headache: from old myths to modern conceptsP Barbanti, G Egeo, C Aurilia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 3, 2011
Migraine prophylaxis: what is new and what we need?P Barbanti, C Aurilia, G Egeo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 23, 2013
Dopaminergic symptoms in migrainePiero Barbanti, L Fofi, C Aurilia, et al.
Expert Opinion on Investigational Drugs|January 20, 2017
Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical developmentPiero Barbanti, C Aurilia, G Egeo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 29, 2015
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraineP Barbanti, G Egeo, L Fofi, et al.
Cephalalgia : an International Journal of Headache|August 30, 2007
A case-control study on excessive daytime sleepiness in episodic migraineP Barbanti, G Fabbrini, C Aurilia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2003
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatmentG Fabbrini, P Barbanti, C Aurilia, et al.
Cephalalgia : an International Journal of Headache|February 10, 2016
The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization. A case series of 757 patientsP Barbanti, C Aurilia, V Dall'Armi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
International Journal of Geriatric Psychiatry|December 19, 2001
Tardive dyskinesias in the elderlyG Fabbrini, P Barbanti, C Aurilia
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 14, 2010
Hypertension as a risk factor for migraine chronificationP Barbanti, C Aurilia, G Egeo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 29, 2014
Treatment of tension-type headache: from old myths to modern conceptsP Barbanti, G Egeo, C Aurilia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 3, 2011
Migraine prophylaxis: what is new and what we need?P Barbanti, C Aurilia, G Egeo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 23, 2013
Dopaminergic symptoms in migrainePiero Barbanti, L Fofi, C Aurilia, et al.
Expert Opinion on Investigational Drugs|January 20, 2017
Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical developmentPiero Barbanti, C Aurilia, G Egeo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 29, 2015
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraineP Barbanti, G Egeo, L Fofi, et al.
Cephalalgia : an International Journal of Headache|August 30, 2007
A case-control study on excessive daytime sleepiness in episodic migraineP Barbanti, G Fabbrini, C Aurilia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2003
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatmentG Fabbrini, P Barbanti, C Aurilia, et al.
Cephalalgia : an International Journal of Headache|February 10, 2016
The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization. A case series of 757 patientsP Barbanti, C Aurilia, V Dall'Armi, et al.
Pageof 2